Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma

Journal of Surgical Oncology

Volumn 98, Issue 7, 2008, Pages 535-539

  Nanashima, Atsushi ^a   Sumida, Yorihisa ^a   Abo, Takafumi ^a   Oikawa, Masayuki ^a   Murakami, Goshi ^a   Takeshita, Hiroaki ^a   Fukuoka, Hidetoshi ^a   Hidaka, Shigekazu ^a   Nagayasu, Takeshi ^a   Sakamoto, Ichiro ^a   Sawai, Terumitsu ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Computed tomography; Hepatectomy; Intrahepatic cholangiocarcinoma; Pattern of tumor enhancement; Prognosis

Indexed keywords

ALPHA FETOPROTEIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; INDOCYANINE GREEN; IOHEXOL;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG RETENTION; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ENHANCEMENT; INTRAHEPATIC CHOLANGIOCARCINOMA; LIVER FUNCTION TEST; LIVER RESECTION; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; VASCULARIZATION; VIRUS HEPATITIS;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CONTRAST MEDIA; FEMALE; HEPATECTOMY; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; IMAGE ENHANCEMENT; IOHEXOL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 56649113039     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21142     Document Type: Article

References (32)

1. Su CH, Tsay SH, Wu CC, et al.: Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg 1996;223:384-394.
2. Isa T, Kusano T, Shimoji H, et al.: Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma. Am J Surg 2001;181:507-511.
3. Kawarada Y, Yamagiwa K, Das BC: Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg 2002;183:679-685.
4. Kozaka K, Sasaki M, Fujii T, et al.: A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'. Histopathology 2007;51:390-400.
5. Roskams T: Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 2006;25:3818-3822.
6. Sano T, Kamiya J, Nagino M, et al.: Macroscopic classification and preoperative diagnosis of intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 1999;6:101-107.
7. Hirohashi K, Uenishi T, Kubo S, et al.: Macroscopic types of intrahepatic cholangiocarcinoma: Clinicopathologic features and surgical outcomes. Hepatogastroenterology 2002;49:326-329.
8. Khan SA, Thomas HC, Davidson BR, et al.: Cholangiocarcinoma. Lancet 2005;366:1303-1314.
9. Torzilli G, Minagawa M, Takayama T, et al.: Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 1999;30:889-893.
10. Lazaridis KN, Gores GJ: Cholangiocarcinoma. Gastroenterology 2005;128:1655-1667.
11. Fukukura Y, Hamanoue M, Fujiyoshi F, et al.: Cholangiolocellular carcinoma of the liver: CT and MR findings. J Comput Assist Tomogr 2000;24:809-812.
12. Yamanaka N, Okamoto E, Ando T, et al.: Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma. Cancer 1995;76:2449-2456.
13. Khan SA, Davidson BR, Goldin R, et al.: Guidelines for the diagnosis and treatment of cholangiocarcinoma: Consensus document. Gut 2002;51:1-9.
14. Jung AY, Lee JM, Choi SH, et al.: CT features of an intraductal polypoid mass: Differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma. J Comput Assist Tomogr 2006;30:173-181.
15. Song SJ, Lee JM, Kim YJ, et al.: Differentiation of intraductal papillary mucinous neoplasms from other pancreatic cystic masses: Comparison of multirow-detector CTand MR imaging using ROC analysis. J Magn Reson Imaging 2007;26:86-93.
16. Nanashima A, Yamaguchi H, Shibasaki S, et al.: Relationship between CT volumetry and functional liver volume using technetium-99m galactosyl serum albumin scintigraphy in patients undergoing preoperative portal vein embolization before major hepatectomy: A preliminary study. Dig Dis Sci 2006;51:1190-1195.
17. Liver Cancer Study group of Japan. Clinical findings. In: Makuuchi M, editor. The general rules for the clinical and pathological study of primary liver cancer. 2nd English edition. Tokyo:Kanehara Co. 2003; pp. 6-28.
18. Park HS, Lee JM, Choi JY, et al.: Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography. Am J Roentgenol 2008;190:396-405.
19. Chamberlain RS, Blumgart LH: Hilar cholangiocarcinoma: A review and commentary. Ann Surg Oncol 1999;7:55-66.
20. Valls C, Guma A, Puig I, et al.: Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging 2000;25:490-496.
21. Sano T, Kamiya J, Nagino M, et al.: Macroscopic classification and preoperative diagnosis of intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 1999;6:101-107.
22. Sanada Y, Yoshida K, Itoh H: Comparison of CT enhancement patterns and histologic features in hepatocellular carcinoma up to 2 cm: Assessment of malignant potential with claudin-10 immunohistochemistry. Oncol Rep 2007;17:1177-1182.
23. Kim NR, Lee JM, Kim SH, et al.: Enhancement characteristics of cholangiocarcinomas on mutiphasic helical CT: Emphasis on morphologic subtypes. Clin Imaging 2008;32:114-120.
24. Kim SJ, Lee JM, Han JK, et al.: Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. Am J Roentgenol 2007;189:1428-1434.
25. Hai S, Kubo S, Yamamoto S, et al.: Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma. Dig Surg 2005;22:432-439.
26. Polizos A, Kelekis N, Sinani C, et al.: Advanced intrahepatic cholangiocarcinoma in hepatitis C virus-related decompensated cirrhosis: Case report and review of the literature. Eur J Gastroenterol Hepatol 2003;15:331-334.
27. Perumal V, Wang J, Thuluvath P, et al.: Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. Hum Pathol 2006;37:1211-1216.
28. Acalovschi M: Cholangiocarcinoma: Risk factors, diagnosis and management. Rom J Intern Med 2004;42:41-58.
29. Yamamoto M, Ariizumi S, Otsubo T, et al.: Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma. J Surg Oncol 2004;87:80-83.
30. Asayama Y, Yoshimitsu K, Irie H, et al.: Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology 2006;238:150-155.
31. Itoh T, Shiro T, Seki T, et al.: Relationship between p53 overexpression and the proliferative activity in hepatocellular carcinoma. Int J Mol Med 2000;6:137-142.
32. Frachon S, Gouysse G, Dumortier J, et al.: Endothelial cell marker expression in dysplastic lesions of the liver: An immunohistochemical study. J Hepatol 2001;34:850-857.